"Prescribing" Exercise to Cancer Patients at High-Risk for Falls |
"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer |
(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer |
[18F] F-GLN by PET/CT in Breast Cancer |
[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy |
[18F]FES PET/CT in Endocrine Refractory Breast Cancer |
[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer |
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer |
[18F]Fluoroestradiol (FES) PET/CT Imaging to Evaluate in Vivo Estrogen Receptor Activity in Endocrine Refractory Recurrent or Metastatic Breast Cancer |
[18F]Fluorothymidine (FLT) PET/CT Imaging In Rb+ Metastatic Breast Cancer Patients Undergoing LEE011 And Weekly Paclitaxel Therapy |
11C-YJH08 PET Imaging for the Detection of Glucocorticoid Receptor Expression in Patients With Metastatic Prostate Cancer |
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer |
18F-DCFPyL PET-CT Scan and Prostate Cancer |
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies |
18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET/CT) For The Evaluation Of Response To Therapy In Bone-Dominant Metastatic Breast Cancer |
18F-fluoroestradiol (FES) PET/CT for Breast Cancer |
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases |
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer |
18F-FMAU PET/CT in Imaging Patients With Advanced Cancers |
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant |
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules |
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy |
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers |
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers |
3 Tesla MRI in Patients With Bladder Cancer |
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer |
3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer |
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer |
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) |
64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) |
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer |
68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer |
68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer |
68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer |
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer |
68Ga-PSMA-11 PET in Patients With Prostate Cancer |
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Ther |
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer |
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
9-ING-41 in Patients With Advanced Cancers |
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors |
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer |
A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients |
A Biobehavioral Intervention for Young Men With Testicular Cancer |
A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer |
A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer |
A Brief Parental Intervention on Learning and Education in Childhood Cancer |
A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF for the Treatment of Advanced Stage Adenocarcinoma |
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. |
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testo |
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors |
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer |
A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers. |
A Community-Based Educational Intervention to Improve Colorectal Cancer Screening |
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have |
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. |
A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients |
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer |
A Comprehensive Approach to Head and Neck Cancer Prehabilitation |
A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors |
A Crowd Sourcing Platform for Patients With Cancer |
A Diagnostic for the Early Detection of Bladder Cancer |
A Distress Screening and Intervention in Cancer Surgery |
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications |
A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions |
A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer |
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 |
A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers |
A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer |
A Dye for the Detection of Cancer of the Tongue and Mouth |
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine |
A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer |
A Five-Year Quality of Life Study for Cancer Patients |
A Gene Hunting Study for Familial Papillary Thyroid Cancer |
A Genotype-Phenotype Urothelial Cancer Registry |
A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform) |
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer |
A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer |
A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors |
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study |
A Multicenter Breast Cancer Biospecimen Registry |
A Multicenter Cancer Biospecimen Collection Study |
A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer |
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer |
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors, Colorectal, and Breast Cancer |
A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation |
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer |
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer |
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants |
A New Psychotherapy Intervention for Older Cancer Patients |
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphe |
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer |
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer |
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals |
A Pancreatic Cancer Screening Study in Individuals With New-Onset Diabetes Mellitus |
A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated |
A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care |
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer |
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. |
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) |
A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer |
A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers |
A Phase 1/2 Study in Patients With Advanced Cancers |
A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers |
A Phase 1/2a Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer |
A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers |
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer |
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) |
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer |
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer |
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) (DeLLphi-301) |
A Phase 2 Trial for Patients With Metastatic Solid Cancer |
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) |
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer |
A Phase I Dose Escalation Study of Single Fraction Pre-operative Stereotactic Partial Breast Irradiation (S-PBI) for Early Stage Breast Cancer |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer |
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients |
A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) |
A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients |
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer |
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer and Homologous Recombination-Deficient Cancers Resistant to PAR |
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WIT |
A Phase II Randomized Study Evaluating Molecular Profiling and Targeted Therapy in Patients With Metastatic Cancer |
A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial |
A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer |
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies |
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment |
A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib |
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer |
A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy |
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer |
A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer |
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy |
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer |
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer |
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer |
A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer |
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care |
A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer |
A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO |
A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer |
A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy |
A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer |
A Research Study for Latina Women Undergoing Breast Cancer Treatment |
A Research Study for Latina Women With Breast Cancer |
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophagea |
A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers |
A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer |
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer |
A Safety Study of SGN-LIV1A in Breast Cancer Patients |
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment |
A Sleep Intervention for Cancer Patients and Their Caregivers |
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE |
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE |
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors |
A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer |
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Li |
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morph |
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer |
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer |
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) |
A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer |
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 in Combination With BI 754091 (Ezabenl |
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated |
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Be |
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer |
A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin |
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens |
A Study of a Telemedicine Program for Older Adults With Cancer |
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer |
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond |
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer |
A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer |
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer |
A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC) |
A Study of Amivantamab in People With Esophagogastric Cancer |
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer |
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC |
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies |
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy |
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following |
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progre |
A Study of Attention and Memory Processes in Breast Cancer Survivors |
A Study of Bemarituzumab Monotherapy and Docetaxel Combination in Participants With Squamous Non-small-cell Lung Cancer (SqNSCLC) With Fibroblast Grow |
A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers |
A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer |
A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer |
A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer |
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers |
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer |
A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer |
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers |
A Study of CC-90011 and Comparators in Participants With Prostate Cancer |
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers |
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer |
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer |
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency o |
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer |
A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer |
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer |
A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer |
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers |
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer |
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer |
A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) |
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast |
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) |
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors |
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Triple Negative Breast Cancer |
A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer |
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer |
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA |
A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer |
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors |
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer |
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest |
A Study of Intra-operative Imaging in Women With Ovarian Cancer |
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer |
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) |
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer |
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants |
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer |
A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients |
A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer |
A Study of Lerociclib in Participants With Advanced Breast Cancer |
A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer |
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients |
A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer |
A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions |
A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment |
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors |
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer |
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery |
A Study of Melphalan, BCNU, Vitamin B12b, Vitamin C, and Stem Cell Infusion in People With Advanced Pancreatic Cancer and BRCA Mutations |
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpo |
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer |
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lu |
A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer |
A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer |
A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy |
A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Remo |
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer |
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer |
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer |
A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors |
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer |
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer |
A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer |
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer |
A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone |
A Study of Optical Imaging With Light From Radiotracers in Cancer Patients |
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer |
A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma |
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer |
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors |
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer |
A Study of PF-06873600 in People With Cancer |
A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer |
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) |
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer |
A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM |
A Study of Radiation Therapy With Pembrolizumab and Olaparib in Women Who Have Triple-Negative Breast Cancer |
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer |
A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors |
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer |
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy |
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers |
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery |
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer |
A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) |
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) |
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) |
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) |
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimm |
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer |
A Study of SEA-CD40 Given With Other Drugs in Cancers |
A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer |
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRET |
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer |
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) |
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer |
A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones |
A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone |
A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer |
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer |
A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers |
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System |
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma |
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of th |
A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) |
A Study of Targeted Agents With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer |
A Study of Tarlatamab (AMG 757) in Participants With Neuroendocrine Prostate Cancer |
A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer |
A Study of TAS-120 in Patients With Metastatic Breast Cancer |
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer |
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer |
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma |
A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer |
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers |
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer |
A Study of the Use of Sentinel Lymph Node Biopsy in Women With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and |
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors |
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer |
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer |
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer |
A Study of U3-1402 in Subjects With Metastatic Breast Cancer |
A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer |
A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation |
A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer |
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer |
A Study of ZN-c3 in Patients With Platinum-Resistant Ovarian Cancer |
A Study of ZN-c5 in Participants With Breast Cancer |
A Study of ZN-c5 in Subjects With Breast Cancer |
A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer |
A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations |
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in Co |
A Study to Assess PV-10 Chemoablation of Cancer of the Liver |
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer |
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer |
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and S |
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) |
A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer |
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer |
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer |
A Study to Determine Whether Chemotherapy, Bevazicumab, and Atezolizumab is Better Than Chemotherapy Alone in Patients With Advanced Liver Cancer |
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer |
A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC) |
A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer |
A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer |
A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients |
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer |
A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer |
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer |
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Re |
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer |
A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer |
A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients |
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer |
A Study to Test Different Doses of BI 1810631 in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) |
A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Muta |
A Study to Test Different Doses of BI 1831169 Alone and in Combination With Ezabenlimab in People With Different Types of Advanced Cancer (Solid Tumor |
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for Delta-Like |
A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) |
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer |
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer |
A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable fo |
A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer |
A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer |
A Supportive Care Intervention for Older Caregivers of Older Adults With Advanced Cancer |
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer |
A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy |
A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer |
A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing |
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. |
A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers |
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects |
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer |
A Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After R |
A Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising |
A Trial of ZL-1201 in Subjects With Advanced Cancer |
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer |
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer |
A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial |
A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer |
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer |
A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport |
A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 |
AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002) |
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts |
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer |
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. |
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer |
Abemaciclib and Letrozole to Treat Endometrial Cancer |
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer |
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer |
Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer |
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
Abemaciclib With Letrozole in Recurrent or Persistent Endometrial Cancer |
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer |
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repai |
Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System |
Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy |
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia |
Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice |
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening |
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer |
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer |
Activating Happiness in Cancer: A Positive Psychology Workshop for Patients, Survivors, and Caregivers |
Active Surveillance for Cancer of the Prostate (ASCaP) |
Acupressure for Fatigue in Ovarian Cancer Survivors |
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery |
Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer |
Acupuncture in Reducing Ileus in Patients Who Have Undergone Surgery for Colorectal Cancer |
Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Patients |
Acute Exercise Intervention in Reducing Breast Cancer Risk in Healthy Participants |
Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy |
Adaptation of Ca-HELP Intervention in Rural Geriatric Cancer Patient Population |
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health |
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients With Localized Pancreatic Cancer |
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer |
Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial |
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy |
Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings |
Addressing Mental Health of Cancer Patients and Caregivers Using a Mobile App Suite |
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer |
Adjuvant Avelumab in Merkel Cell Cancer |
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer |
Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients |
Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer |
Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer |
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm |
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer |
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers |
ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) |
Advanced Care Planning Using the Five Wishes Document in Young Patients With Metastatic, Recurrent, or Progressive Cancer or HIV Disease |
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer |
Advanced Diffusion Tensor MRI for Breast Cancer |
Advanced or Recurrent Ovarian, Cervical, and Endometrial Cancer Treated With SHetA2 |
Afatinib in Advanced Refractory Urothelial Cancer |
African American Families Fighting Parental Cancer Together |
AIMS Cancer Outcomes Study |
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) |
AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer |
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer |
Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening |
Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer |
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer |
All-extremity Exercise During Breast Cancer Chemotherapy |
All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer |
Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer |
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer |
Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer |
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected |
Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer |
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer |
Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors |
Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer |
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC) |
An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivor |
An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer |
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer |
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors |
An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer |
An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Che |
An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer |
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer |
An Internet-based Program to Help Cancer Survivors Manage Pain |
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer |
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers |
An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancer |
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer |
An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer |
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer |
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer Undergoing Radiation Therapy and/or Systemic Therapy |
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment R |
An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer |
An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread |
An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing |
An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE) |
An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study |
An Online Cognitive Assessment in Cancer Patients |
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer |
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer |
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer |
Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy |
Anamorelin Study for Advanced Pancreatic Cancer |
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer |
Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients |
Androgen Deprivation, With or Without pTVG-AR, and With or Without Nivolumab, in Patients With Newly Diagnosed, High-Risk Prostate Cancer |
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery |
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer |
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer |
Anti-anxiety Biotics for Breast Cancer Survivors |
Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patient With Advanced Cancer |
Anti-ESO (Cancer/Test Antigen) mTCR-transduced Autologous Peripheral Blood Lymphocytes and Combination Chemotherapy in Treating Patients With Metastat |
Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy |
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer |
Apalutamide With or Without Stereotactic Body Radiation Therapy in Treating Participants With Castration-Resistant Prostate Cancer (PILLAR) |
APG-115 in Salivary Gland Cancer Trial |
Apollo Device for Metastatic Breast Cancer (MBC) |
App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer |
Appetite and Exercise in Breast Cancer Survivors |
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma |
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients |
Arizona Cancer Center Biospecimen Repository |
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, th |
Aromatherapy for Integrated Cancer Care |
ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing |
Artificial Intelligence for Prostate Cancer Treatment Planning |
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) |
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents |
ASP-1929 Photoimmunotherapy (PIT) Study in in Patients With Recurrent Head/Neck Cancer |
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy |
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension |
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery |
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) |
Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer |
Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer |
Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity |
Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS) |
Assessment of Amide-Proton-Transfer MRI in Prostate Cancer |
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes |
Assessment of Candidate Protein Expression in Breast Cancer Specimens |
Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer |
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer |
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients |
Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy |
Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer |
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients |
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce |
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer |
Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer |
Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer |
Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site |
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer |
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer |
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer |
Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer |
Atezolizumab, Oxaliplatin, and Fluorouracil in Treating Patients With Esophageal or Gastroesophageal Cancer |
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving |
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer |
Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study |
Autoantibodies in Breast Cancer Detection |
Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) |
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer |
Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer |
Automated Device for Asthma Monitoring and Management in Monitoring Adult Patients With Lung Cancer Undergoing Radiation Therapy |
Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer |
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
AVB-S6-500 (Batiraxcept)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer |
Avelumab and Radiation in Muscle-Invasive Bladder Cancer |
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in |
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer |
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer |
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid |
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection |
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer |
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer |
AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or O |
AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL |
AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer |
Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment |
Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors |
BATs in Patients With Breast Cancer and Leptomeningeal Metastases |
BATs Treatment for Pancreatic Cancer, Phase Ib/II |
BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy |
Be-Active Study - Increasing Physical Activity in Cancer Survivors |
Beat Childhood Cancer Specimen Banking and Data Registry |
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer |
Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship |
Behavioral Nudges to Improve Palliative Care Utilization in Advanced Cancer |
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression |
Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250) |
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer |
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer |
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer |
Bevacizumab and Ixabepilone in Treating Patients With Advanced Kidney Cancer |
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery |
Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer |
Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members |
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer |
Bilingual Electronic Symptom Management Program Across Multi-site, Comprehensive Cancer Center |
Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation |
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer |
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer |
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer |
Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer |
Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms |
Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer |
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) |
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib |
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors |
Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer |
Biomarkers for Risk Stratification in Lung Cancer |
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers |
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA1 |
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer |
Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer |
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer |
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer |
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Ca |
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Under |
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) |
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer |
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer |
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers |
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast |
Blood Markers of Early Pancreas Cancer |
Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters |
Blood Sample Collection for Experimental Blood Test to Track Liver Cancer |
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer |
Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy |
BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors |
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer |
Body Composition During Cancer Treatment |
Body Composition Post Cancer Treatment |
Body Image After Head and Neck Cancer Treatment |
Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer |
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture |
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer |
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer |
Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC) |
Brain Health in Breast Cancer Survivors |
Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors |
BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer |
Breast Cancer and Resistance Exercise Program |
Breast Cancer BRCA1 Carriers: a Pilot Study |
Breast Cancer Index (BCI) Registry |
Breast Cancer Liquid Biopsy Trial |
Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer |
Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory |
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer |
Breast Cancer Self-Efficacy Scale for Partners |
Breast Imaging Using Indium In 111 CHX-A DTPA Trastuzumab in Patients With Primary Cancer or Metastatic Cancer |
BreastVax: Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer |
Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy |
Breathwork App for Cancer Survivors |
Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer |
Brief Behavioral Treatment for Insomnia in Cancer Survivors |
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer |
Bronchoscopic Cryo-Immunotherapy of Lung Cancer |
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) |
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC |
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients |
Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors |
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) |
Cabiralizumab in Combination With Nivolumab and Neoadjuvant Chemotherapy in Patients With Localized Triple-negative Breast Cancer |
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial |
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer |
Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer |
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer |
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increase |
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies |
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma |
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) |
Calcitriol in Preventing Lung Cancer in High-Risk Patients |
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial |
Cancer Activity and Lifestyle Measurement Study |
Cancer and Blood Pressure Management, CARISMA Study |
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance |
Cancer Experience Registry: An Online Research Study to Understand the Experiences of Cancer Patients and Caregivers |
Cancer Financial Experience |
Cancer Genetic Testing in Ethnic Populations |
Cancer in Inherited Bone Marrow Failure Syndromes |
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment |
Cancer Leadership Training for Clergy Wives and Widows |
Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum |
Cancer Risk in Individuals Who Have a Xeroderma Pigmentosum Gene Alteration Compared With Those Who Don't |
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease |
Cancer Screening; Access; Awareness; Navigation |
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer |
Cancer Stem Cell High-Throughput Drug Screening Study |
Cancer Stem Cells in Acute Leukemia |
Cancer Survivor Cardiomyopathy Detection |
Cancer Therapy Effects on the Heart |
Cancer Within a Pandemic: A Telemental Health Intervention |
Cannabis Use in Cancer Patients |
Cannabis Use Patterns Among Cancer Patients |
Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer |
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer |
Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer |
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer |
Capivasertib + Palbociclib + Fulvestrant for HR+/HER2- Advanced Breast Cancer (CAPItello-292). |
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency |
CAR T Cells in Mesothelin Expressing Cancers |
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance |
Carbon Ion RT for Locally Advanced Pancreatic Cancer |
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer |
Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot |
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer |
Cardiac Autonomic Dysfunction in Childhood Cancer Survivors |
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers |
Cardiomyopathy Tissue Bank in a Cancer Population |
Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation |
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue |
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue |
Care Transition Intervention for Hospitalized Patients With Advanced Cancer |
Caregivers' and Cancer Survivors' Psychological Distress & Symptom Management |
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer |
Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome |
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer |
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer |
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer |
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T |
Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer |
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer |
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer |
CELLO-1, Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Subjects With Castration Resistant Prostate Cancer Who Have Not Received |
Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disea |
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer |
Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer |
Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery |
Central Obesity and Cancer Prevention for Chinese American Women |
Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study) |
Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer |
Cervical Cancer Prevention for Black Adults |
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer |
Cetuximab and/or Dasatinib in Treating Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery |
Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer |
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer |
cfMeDIP-seq Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
Changes in Brain Function in Patients With Breast Cancer or Lymphoma Receiving Chemotherapy |
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy |
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer |
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes in Non-metastatic, Non-recurrent Lung and Esophageal Cancer Patients |
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors |
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer |
Chemo-embolization for Head and Neck Cancer |
Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer |
Cervical Cancer Detection Using Optical Spectroscopy |
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer |
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer |
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients |
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer |
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer |
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases |
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer |
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver |
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer Th |
Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients |
Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer |
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
Chiauranib for Relapsed/Refractory Small Cell Lung Cancer |
Childhood Cancer Predisposition Study (CCPS) |
Childhood Cancer Survivor Study |
Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening |
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer |
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency |
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer |
Chromogranin A as Blood Marker in Cancer Patients |
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer |
CIML NK Cell in Head & Neck Cancer |
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer |
Circulating microRNAs as Disease Markers in Pediatric Cancers |
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy |
Circulating Tumor Cells (CTC) in Lung Cancer |
Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer |
Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab |
Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers in Patients Undergoing Regional Nodal Irradiation for Breast Cancer |
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer |
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery |
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer |
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery |
Cisplatin in Castration Resistant Prostate Cancer |
Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer |
Cisplatin+Pembrolizumab+RT in Vulvar Cancer |
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer |
Claudin18.2 CAR-T (CT041) in Patients With Gastric or Pancreatic Cancer |
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer |
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer |
Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients |
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer |
Clinical Impact of Respiratory-Swallow Training on Refractory Dysphagia in Oropharyngeal Head and Neck Cancer |
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer |
Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer |
Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and |
Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer |
Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer |
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer |
Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers |
Clinical Trial to Evaluate ARV-766 in Patients With Metastatic Castration-Resistant Prostate Cancer |
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C" |
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy |
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment |
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer |
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. |
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma |
CMP-001 in Combination With IV PD-1-Blocking Antibody in Subjects With Certain Types of Advanced or Metastatic Cancer |
CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Blood Cancer Undergoing Donor Stem Cell Transplant |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
COG Registry - Childhood Cancer Research Network (CCRN) |
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer |
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy |
Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer |
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer |
Cohort Study of Pancreatic Cancer Risk |
Collaborative Care Intervention for Cancer Caregivers |
Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Tumors |
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer |
Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinic |
Collecting and Storing Tissue and Fluid Samples From Patients Receiving Standard Care at the National Cancer Institute |
Collecting and Storing Tissue From Young Patients With Cancer |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders |
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer |
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants |
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients |
Collection and Storage of Tissue and Blood Samples From Patients With Cancer |
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer |
Collection of Blood From Patients With Cancer |
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis |
Collection of Blood From Patients With Prostate Cancer |
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer |
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer |
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance |
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment |
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers |
Collection of Information to Better Understand Young Onset Colorectal Cancer |
Collection of Outcomes Data for Pregnant Patients With Cancer |
Collection of Sputum and Labeling for Lung Cancer |
Collection of Tissue Blocks or Slides From Patients With Cancer |
Collection of Tissue Samples for Cancer Research |
ColoCare Study - Colorectal Cancer Cohort |
COLON-MD: Colon Cancer Longitudinal Study |
Colorectal Cancer (CRC) Surveillance Tool: Cognitive and Pilot Testing |
Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study |
Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health |
Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer |
Combination Chemotherapy and Bevacizumab in Treating Patients With Recurrent, Unresectable, or Metastatic Gastric Cancer, Gastroesophageal Junction Ca |
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair |
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the C |
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer |
Combination of TATE and PD-1 Inhibitor in Liver Cancer |
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer |
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer |
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients |
Combined Immunotherapies in Metastatic ER+ Breast Cancer |
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors |
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer |
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients |
Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners |
Communication Training for Cancer Patients, Their Caregivers, and Their Doctors |
Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer |
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Chemotherap |
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers |
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer |
Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center |
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer |
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer |
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening |
Comparing the New Anti-cancer Drug Eribulin With or Without Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer |
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PR |
Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease |
Comparing Virtual Yoga to Standard Care on Insomnia Among Cancer Survivors |
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy |
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer |
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer |
Comparison of Nodal Staging in Endometrial Cancer |
|